InflaRx NV (IFRX)

0.9336 +0.05 (+5.86%) USD  |  NASDAQ  |  Feb 25, 16:00
0.918 -0.02 (-1.67%) After-Hours: 20:00
More

InflaRx Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for IFRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
CDT Equity, Inc. Upgrade
LENZ Therapeutics, Inc. Upgrade
Liminatus Pharma, Inc. Upgrade
Oruka Therapeutics, Inc. Upgrade
Maze Therapeutics, Inc. Upgrade